According to the latest report by IMARC Group, titled "Extracorporeal Membrane Oxygenation Machine Market Report by Component (Pumps, Oxygenator, Controllers, Cannula, Accessories), Modality (Veno-Arterial, Veno-Venous, Arterio-Venous), Patient Type (Neonates, Pediatric, Adult), Application (Respiratory, Cardiac, ECPR), and Region 2025-2033," the The global extracorporeal membrane oxygenation machine market size reached USD 559.7 Million in 2024. Extracorporeal membrane oxygenation (ECMO) machine offers prolonged cardiac and respiratory support to patients during transplant surgeries. This miniaturized heart-lung equipment is used for draining the blood for oxygenating red blood cells (RBCs), removing carbon dioxide from the patient’s body and then pumping to circulate blood via an artificial lung back into the bloodstream of the individual. Apart from this, these devices can also be utilized in late-stage treatments or post-cardiopulmonary bypass with heart or lung failure.
Global Extracorporeal Membrane Oxygenation Machine Market Trends:
The global market is majorly driven by the rising prevalence of respiratory and cardiovascular disorders. This is also supported by the growing geriatric population across the globe that is more prone to develop such medical conditions. Since ECMO is widely used for individuals suffering from respiratory or cardiac failure as a result of trauma, congenital disabilities or severe infections, this is providing a boost to the market growth. The market is further driven by the continual integration of ECMO devices with advanced technologies. For instance, the advent of polymethyl pentene (PMP) fiber-based artificial membranes with enhanced biocompatibility and low resistance is gaining widespread prominence across healthcare settings. Looking forward, the market value is projected to reach USD 913.9 Million by 2033, expanding at a CAGR of 5.32% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Million USD |
Segment Coverage | Component, Modality, Patient Type, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | Abbott Laboratories, ALung Technologies Inc., Braile Biomedical, Eurosets, LivaNova PLC, Medtronic, MicroPort Scientific Corporation, Nipro Medical Corporation, Origen Biomedical, Inc., Terumo Corporation and Xenios AG |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800